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PROF. HARALD  MISCHAK (Orcid ID : 0000-0003-0323-0306)
Article type      : Letter
To the Editor of the European Journal of Clinical Investigation
Re-analysis of “Peptidomic analysis of cartilage and subchondral bone in OA patients”
Dear Editor,
In the May 2019 issue of European Journal of Clinical Investigation, Gatenholm et al. reported on 
"a method for directly analyzing osteochondral samples straight out of the operating room 
without cell culturing, thereby enabling identification of potential peptide biomarkers to better 
understand the mechanisms involved in the development of osteoarthritis (OA) and pain"1. Six 
Samples from patients were investigated, 3 from wounded (WO) and 3 from macroscopically 
unwounded zones (UOA) of the femur condyle, manifesting OA based on total knee arthroplasty 
(TKA). Using peptidomics and Tandem Mass Tag (TMT) labeling, the authors in their study 
reported the identification of 6296 endogenous peptides derived from 915 proteins (889 protein 
groups) across samples. Out of the total number of obtained peptide sequences, 601 peptides 
carried TMT labeling and 462 endogenous peptides could be matched and identified in the 
human database, as provided in Table S1. After performing statistical analysis, 566 peptides 
differing (p≤0.1) in unwounded (UOA) and wounded zones from cartilage and subchondral bone 










This article is protected by copyright. All rights reserved
The content and the results in the manuscript appear to be of high importance, especially 
towards the identification of peptide biomarkers for diagnosis of osteoarthritis (OA) patients. We 
aimed at exploiting these published data, specifically integrate them with in house generated 
datasets acquired in our laboratory2, as a basis to identify urine peptides significantly 
deregulated in osteoarthritis. 
Towards that end, re-evaluation of the reported findings was initiated. In total, 18 raw files from 
6 patients analyzed in triplicates were provided by the authors upon request. According to the 
manuscript, the samples were labeled with TMT6-plex, with reporter 126, 127, 128 
corresponding to healthy cartilage, and reporter 129, 130, 131 to OA tissue. We evaluated the 
data using Proteome Discoverer 1.4 by applying the same parameters as reported in the 
manuscript. Using TMT6-plex as fixed modification in the initial data evaluation resulted in a very 
low number of identifications, likely due to very low labeling efficiency. Therefore, TMT6-plex 
and oxidation of methionine and proline (to account for hydroxyproline, a frequent modification 
in collagen) were set as variable modifications. No enzyme specificity was selected, precursor 
mass was set to 600 - 5000 Da with a minimum peak count of 10. Percolator algorithm was used 
for the calculation of the FDR level for the peptide spectrum matches (PSMs). Peptides identified 
with high and medium confidence (FDR <5%.) were considered for further analysis.
In total, 16 out of the 18 raw files were evaluated (2 files could not be processed successfully), 
resulting in identified of 3073 endogenous peptide sequences. Of these, only 1017 peptide 
sequences were identified in at least 3 of the 16 datasets, 2056 peptide sequences being 
identified in less than 3 datasets (Supplementary table 1). All sequences identified were 
compared to those reported in the manuscript. Overall, 2055 common peptide sequences could 
be found. Surprisingly, the majority of the peptide sequences reported in the manuscript (4241) 
could not being confirmed. Since each patient sample was analyzed in triplicate, we next 
assessed the number of consistent peptides identified in the entire dataset (detectable in >70% 
of all analyses) or per sample (consistence was defined as detection in at least 2 out of the 3 
experiments) . Only 82 peptides were detected in at least 70% (12 or more) of all datasets. A 
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(between 40 and 450 peptides per sample, see supplementary table 1). Overall, these data 
indicate very low consistency.
Even though identical parameters for data evaluation were applied, based on the methodology 
reported in the original manuscript and adjusted based on further information obtained, the 
results that were obtained, were highly different, most of the reported findings could not be 
reproduced. When trying to understand the analytical causes for this discrepancy, multiple 
different settings were tested which revealed some apparent errors in the methods as reported 
in the manuscript, as listed below: 
1. Although the authors indicate that the samples were first TMT labeled, then combined 
and the combined sample was subsequently analyzed (see Figure 1), it seems the samples 
were in fact analyzed separately, likely due to insufficient TMT labeling. 
2. The authors described application of the TMT label as fixed modification. However, after 
evaluating and subsequent discussion with one of the co-authors it became evident that 
the TMT label has been set as "variable modification" in the data evaluation methods. 
These changes do have a huge impact on the results returned.
Although this is a small pilot study, which is mentioned as limitation together with issues of small 
sample amount and difficulties in labeling and quantification of the OA peptides and issues with 
peptide identification; still it is necessary to be accurate when describing the methods used and 
the analytical protocols, to allow data replication, re-use and further exploration. 
We thus feel it is of outmost importance to share these results for several highly relevant 
reasons:
1) The results indicate the enormous importance of accurately describing the methods used. The 
application of methods different from the one described in the manuscript, as apparently was 
the case here, does have a huge impact on the results obtained and prevents any effort of 
reproducing the results; basically no similarity exists between the results obtained using the 
method described in the manuscript and using the method that likely has actually been 
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2) The data available also indicate that application of two different software solutions, both using 
identical data and parameters, and both intended for the same purpose, appears to result in very 
different outputs (here: lists of peptides). It is unknown which of the two are correct, but it is 
certain that they cannot both be correct. If only the output, ie. the results after data 
interpretation by the software is being reported (the list of peptides), possibly even with 
additional impact by the authors of the study (e.g. selective reporting of only some features), 
then reproducibility may be completely lost. The same dataset, as a result of applying different 
software solutions and interpretation by the authors, may give completely different final results. 
This is very worrying and an easy solution is not evident. Data evaluation using different software 
solutions is has been shown to be helpful3, but may not always be practical.
3) This finding further underlines the enormous importance of mandatory sharing of the raw 
(machine) data, which the authors did. On multiple occasions unfortunately scientists refuse  
sharing of the raw data, arguing that data protection issues prevent sharing (e.g. 4). In light of the 
findings reported here, data sharing should be mandatory for any publication in respected 
scientific journals. Accepting refusal of data sharing results in potentially accepting major errors 
in publications, even scientific misconduct as the results published cannot be reproduced by 
anybody, due to the absence of data. We, as a scientific community, must not support the abuse 
of data protection to cover up questionable scientific conduct. Even though not mandatory, the 
authors here did share the raw data and, in this way, enabled uncovering these highly relevant 
issues. The claims made in the manuscript can probably not be upheld any longer or need at least 
major revision, however, by sharing all data the authors demonstrated commendable scientific 
conduct.
Sincerely
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